Tom Frohlich
Net Worth

Last updated:

What is Tom Frohlich net worth?

The estimated net worth of Mr. Tom Frohlich is at least $3,415,833 as of 10 Feb 2023. He has earned $1,710,113 from insider trading and has received compensation worth at least $1,705,720 in Chinook Therapeutics, Inc..

What is the salary of Tom Frohlich?

Mr. Tom Frohlich salary is $426,430 per year as Chief Operating Officer in Chinook Therapeutics, Inc..

How old is Tom Frohlich?

Mr. Tom Frohlich is 49 years old, born in 1976.

What stocks does Tom Frohlich currently own?

As insider, Mr. Tom Frohlich owns shares in one company:

Company Title Shares Price per share Total value
Chinook Therapeutics, Inc. (KDNY) Chief Operating Officer 150,777 $0 $0

What does Chinook Therapeutics, Inc. do?

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.

KDNY logo
KDNY
Chinook Therapeutics, Inc.

Tom Frohlich insider trading

Chinook Therapeutics, Inc.

Mr. Tom Frohlich has made 10 insider trades between 2021-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 20,000 units of KDNY stock on 24 Sep 2021. As of 10 Feb 2023 he still owns at least 150,777 units of KDNY stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 6,803 N/A N/A
Option
Common Stock 6,803 N/A N/A
Sale
Common Stock 3,700 $23.75 $87,871
Option
Common Stock 8,333 N/A N/A
Sale
Common Stock 4,566 $24.68 $112,698
Option
Restricted Stock Unirt 8,333 N/A N/A
Option
Common Stock 10,000 $0.42 $4,200
Option
Employee Stock Option (right to buy) 10,000 $0.42 $4,200
Sale
Common Stock 10,000 $25 $250,010
Sale
Common Stock 10,000 $22.16 $221,640
Option
Common Stock 10,000 $0.42 $4,200
Option
Employee Stock Option (right to buy) 10,000 $0.42 $4,200
Sale
Common Stock 7,360 $19.69 $144,933
Option
Restricted Stock Units (RSU) 13,582 N/A N/A
Option
Common Stock 13,582 N/A N/A
Sale
Common Stock 3,735 $12.74 $47,588
Option
Restricted Stock Units (RSU) 6,802 N/A N/A
Option
Common Stock 6,801 N/A N/A
Sale
Common Stock 6,230 $15.48 $96,440
Option
Employee Stock Option (right to buy) 15,000 $0.42 $6,300
Sale
Common Stock 13,770 $15.17 $208,932
Sale
Common Stock 20,000 $14 $280,000
Option
Common Stock 15,000 $0.42 $6,300
Option
Common Stock 13,580 N/A N/A
Option
Restricted Stock Units (RSU) 13,580 N/A N/A
Option
Employee Stock Option (right to buy) 20,000 $0.42 $8,400
Option
Common Stock 20,000 $0.42 $8,400
Sale
Common Stock 20,000 $13 $260,000

Chinook Therapeutics key executives

Chinook Therapeutics, Inc. executives and other stock owners filed with the SEC: